Get started
Author

Tomohiro Sakamoto

Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer
2020 · Alexander Drilon, Geoffrey R. Oxnard, et al. · New England Journal of Medicine · 858
PDF
First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon EGFR Mutations
2023 · Yusuke Okuma, Kaoru Kubota, et al. · JAMA Oncology · 97
Trastuzumab emtansine for patients with non–small cell lung cancer positive for human epidermal growth factor receptor 2 exon-20 insertion mutations
2021 · Eiji Iwama, Yoshitaka Zenke, et al. · European Journal of Cancer · 82
PDF
PL02.08 Registrational Results of LIBRETTO-001: A Phase 1/2 Trial of LOXO-292 in Patients with RET Fusion-Positive Lung Cancers
2019 · A. Drilon, G. Oxnard, et al. · Journal of Thoracic Oncology · 82
PDF
Phase II study of tepotinib in NSCLC patients with METex14 mutations.
2019 · Paul K. Paik, Remi Veillon, et al. · Journal of Clinical Oncology · 64
Multiplex gene‐panel testing for lung cancer patients
2020 · Yasushi Yatabe, Kuniko Sunami, et al. · Pathology International · 62
Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non–Small Cell Lung Cancer
2023 · Yoshimasa Shiraishi, Junji Kishimoto, et al. · JAMA Oncology · 58
Biomarker Testing in Patients With Unresectable Advanced or Recurrent Non–Small Cell Lung Cancer
2023 · Tomohiro Sakamoto, Taichi Matsubara, et al. · JAMA Network Open · 39
PDF
Nivolumab‑induced cholangitis in patients with non‑small cell lung cancer: Case series and a review of literature
2019 · Hiroki Izumi, Masahiro Kodani, et al. · Molecular and Clinical Oncology · 30
PDF
Japanese Lung Cancer Society Guidelines for Stage IV NSCLC With EGFR Mutations
2020 · Kiichiro Ninomiya, Shunsuke Teraoka, et al. · JTO Clinical and Research Reports · 29
PDF
DNA-PK Inhibition by NU7441 Enhances Chemosensitivity to Topoisomerase Inhibitor in Non-Small Cell Lung Carcinoma Cells by Blocking DNA Damage Repair.
2017 · Masaaki Yanai, Haruhiko Makino, et al. · PubMed · 28
Tepotinib in patients with NSCLC harbouring MET exon 14 skipping: Japanese subset analysis from the Phase II VISION study
2021 · Hiroshi Sakai, Masahiro Morise, et al. · Japanese Journal of Clinical Oncology · 27
PDF
Phase III Clinical Trial for the Combination of Erlotinib Plus Ramucirumab Compared With Osimertinib in Previously Untreated Advanced or Recurrent Non–Small Cell Lung Cancer Positive for the L858R Mutation of EGFR: REVOL858R (WJOG14420L)
2021 · Naoki Haratake, Hidetoshi Hayashi, et al. · Clinical Lung Cancer · 25
PDF
A Single-Arm Phase 2 Study of Sotorasib Plus Carboplatin and Pemetrexed in Patients With Advanced Nonsquamous NSCLC With KRAS G12C Mutation (WJOG14821L, SCARLET)
2025 · Hiroaki Akamatsu, Shinya Sakata, et al. · Journal of Thoracic Oncology · 22
PDF
Safety and anti-tumor activity of BAY 2927088 in patients with HER2-mutant NSCLC: Results from an expansion cohort of the SOHO-01 phase I/II study.
2024 · Nicolas Girard, Tae Min Kim, et al. · Journal of Clinical Oncology · 18
Tumor Microenvironment Landscape of NSCLC Reveals Resistance Mechanisms for Programmed Death-Ligand 1 Blockade After Chemoradiotherapy: A Multicenter Prospective Biomarker Study (WJOG11518L:SUBMARINE)
2023 · Koji Haratani, Atsushi Nakamura, et al. · Journal of Thoracic Oncology · 18
PDF
Therapeutic impact of mutation subtypes and concomitant STK11 mutations in KRAS–mutated non-small cell lung cancer (NSCLC): A result of nationwide genomic screening project (LC-SCRUM-Japan).
2020 · Yutaro Tamiya, Yoshitaka Zenke, et al. · Journal of Clinical Oncology · 15
Long‐term experience with tepotinib in Japanese patients with MET exon 14 skipping NSCLC from the Phase II VISION study
2024 · Masahiro Morise, Terufumi Kato, et al. · Cancer Science · 14
Acute-phase reaction induced by zoledronate and its effect on prognosis of patients with advanced non-small cell lung cancer
2018 · Hiroki Izumi, Akira Yamasaki, et al. · Lung Cancer · 11
An onion farmer with a case of hypersensitivity pneumonitis caused by Aspergillus niger
2017 · Tomohiro Sakamoto, Akira Yamasaki, et al. · Respiratory Medicine Case Reports · 11
PDF
Frequency of Epidermal Growth Factor Receptor Mutation in Smokers with Lung Cancer Without Pulmonary Emphysema
2017 · KENICHI TAKEDA, AKIRA YAMASAKI, et al. · Anticancer Research · 11
PDF
Increased Autoantibodies Against Oxidized Low-Density Lipoprotein in Coronary Circulation in Patients with Coronary Spastic Angina
2001 · Hisao Ogawa, Hirofumi Soejima, et al. · Angiology · 10
A novel point-of-care system for high-speed real-time polymerase chain reaction testing for epidermal growth factor receptor mutations in bronchial lavage fluids after transbronchial biopsy in patients with non-small cell lung cancer
2015 · TOMOHIRO SAKAMOTO, MASAHIRO KODANI, et al. · International Journal of Oncology · 9
PDF
A new rapid method for detecting epidermal growth factor receptor mutations in non-small cell lung cancer
2015 · MIYAKO TAKATA, HIROKI CHIKUMI, et al. · Oncology Reports · 9
PDF
Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer
2024 · Koji Haratani, Atsushi Nakamura, et al. · British Journal of Cancer · 8
PDF
Works count: 72
Citation count: 1,720
H-index: 16
I10-index: 22
Year
Topic
Type